Free Trial

InnovAge (OTCMKTS:INNV) Stock Passes Above 50 Day Moving Average - What's Next?

InnovAge logo with Medical background

Shares of InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $5.93 and traded as high as $6.69. InnovAge shares last traded at $6.30, with a volume of 84,769 shares trading hands.

InnovAge Stock Down 3.8 %

The stock has a market capitalization of $821.11 million, a price-to-earnings ratio of -37.88 and a beta of 0.39. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.25. The firm has a 50-day moving average of $5.92 and a two-hundred day moving average of $5.37.

InnovAge (OTCMKTS:INNV - Get Free Report) last posted its quarterly earnings results on Tuesday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. InnovAge had a negative net margin of 6.17% and a negative return on equity of 13.04%. The business had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. As a group, sell-side analysts anticipate that InnovAge Holding Corp. will post -0.25 earnings per share for the current year.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

See Also

Should you invest $1,000 in InnovAge right now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines